OrbiMed Capital GP IV LLC
CIK 1502240 · last filed 2024-07-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$13.48M
Companies
9
Total Filings
30
Lifetime Open-Market Net
-$678.12M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TELA | 10%+ Owner | 5,485,084 | $0.86 | $4.72M | $5.96M | 2 | 2024-07-02 |
| ALEC | 10%+ Owner | 1,921,804 | $1.53 | $2.94M | -$244.48M | 7 | 2020-04-16 |
| Principia Biopharma Inc. (PRNB) Delisted | 10%+ Owner | 1,605,713 | — | — | -$52.00M | 2 | 2019-05-22 |
| BOLD | 10%+ Owner | 4,129,638 | $1.41 | $5.82M | -$56.95M | 1 | 2017-09-29 |
| Relypsa Inc (RLYP) Delisted | 10%+ Owner | 7,664,171 | — | — | -$233.05M | 6 | 2015-12-23 |
| OTONOMY, INC. (OTIC) Delisted | Director | 2,245,300 | $0.08 | $172.9K | -$11.88M | 1 | 2015-11-19 |
| INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Director | 1,120,609 | $19.00 | $21.29M | -$84.48M | 5 | 2015-07-21 |
| Mirati Therapeutics, Inc. (MRTX) Delisted | 10%+ Owner | 1,267,000 | $58.70 | $74.37M | $6.00M | 1 | 2015-02-05 |
| Anthera Pharmaceuticals Inc (ANTH) Delisted | Director | 7,462,000 | — | — | -$7.23M | 5 | 2013-02-01 |
Recent Filings · Page 2 of 3
30 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-09-20 | Principia Biopharma Inc. (PRNB) Delisted | Mixed | +5,211,426 | $8.50M | EDGAR |
| 2017-09-29 | BOLD | Sell (S) | −2,016,000 | -$56.95M | EDGAR |
| 2015-12-23 | Relypsa Inc (RLYP) Delisted | Sell (S) | −1,500,000 | -$40.76M | EDGAR |
| 2015-11-19 | OTONOMY, INC. (OTIC) Delisted | Sell (S) | −415,194 | -$11.88M | EDGAR |
| 2015-10-22 | Relypsa Inc (RLYP) Delisted | Buy (P) | +1,500,000 | $18.84M | EDGAR |
| 2015-07-21 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Grant (A) | +855 | $0 | EDGAR |
| 2015-05-20 | Relypsa Inc (RLYP) Delisted | Sell (S) | −4,372,653 | -$149.24M | EDGAR |
| 2015-02-05 | Mirati Therapeutics, Inc. (MRTX) Delisted | Buy (P) | +300,000 | $6.00M | EDGAR |
| 2014-09-18 | Relypsa Inc (RLYP) Delisted | Sell (S) | −282,000 | -$7.13M | EDGAR |
| 2014-08-27 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Sell (S) | −333,774 | -$99.48M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.